![Cureus | Ivermectin Prophylaxis Used for COVID-19: A Citywide, Prospective, Observational Study of 223,128 Subjects Using Propensity Score Matching | Article Cureus | Ivermectin Prophylaxis Used for COVID-19: A Citywide, Prospective, Observational Study of 223,128 Subjects Using Propensity Score Matching | Article](https://assets.cureus.com/uploads/figure/file/313516/lightbox_8d780c4074aa11ec94c4251e4bb8ffa2-Figure-1.-Underlying-data-for-the-study-on-ivermectin-prophylaxis-used-for-COVID-19..png)
Cureus | Ivermectin Prophylaxis Used for COVID-19: A Citywide, Prospective, Observational Study of 223,128 Subjects Using Propensity Score Matching | Article
![Fifteen-Year Trends in Risk Severity and Operative Mortality in Elderly Patients Undergoing Coronary Artery Bypass Graft Surgery | Circulation Fifteen-Year Trends in Risk Severity and Operative Mortality in Elderly Patients Undergoing Coronary Artery Bypass Graft Surgery | Circulation](https://www.ahajournals.org/cms/asset/884d3801-dbd6-433f-bb5d-831fa5cc5ba0/hc0680079001.jpg)
Fifteen-Year Trends in Risk Severity and Operative Mortality in Elderly Patients Undergoing Coronary Artery Bypass Graft Surgery | Circulation
![Nutrients | Free Full-Text | Pre-Therapeutic Sarcopenia among Cancer Patients: An Up-to-Date Meta-Analysis of Prevalence and Predictive Value during Cancer Treatment Nutrients | Free Full-Text | Pre-Therapeutic Sarcopenia among Cancer Patients: An Up-to-Date Meta-Analysis of Prevalence and Predictive Value during Cancer Treatment](https://www.mdpi.com/nutrients/nutrients-15-01193/article_deploy/html/images/nutrients-15-01193-g001.png)
Nutrients | Free Full-Text | Pre-Therapeutic Sarcopenia among Cancer Patients: An Up-to-Date Meta-Analysis of Prevalence and Predictive Value during Cancer Treatment
Clinical presentations, diagnostics, treatments and treatment costs of children and adults with febrile illness in a tertiary referral hospital in south-eastern Guinea: A retrospective longitudinal cohort study | PLOS ONE
![JCM | Free Full-Text | Does Time-to-Chemotherapy after Primary Complete Macroscopic Cytoreductive Surgery Influence Prognosis for Patients with Epithelial Ovarian Cancer? A Study of the FRANCOGYN Group JCM | Free Full-Text | Does Time-to-Chemotherapy after Primary Complete Macroscopic Cytoreductive Surgery Influence Prognosis for Patients with Epithelial Ovarian Cancer? A Study of the FRANCOGYN Group](https://www.mdpi.com/jcm/jcm-10-01058/article_deploy/html/images/jcm-10-01058-g001.png)